FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic Atrophy

TOKYO, Aug. 5, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, " Astellas " ), today announced the U.S. Food and Drug Administration (FDA) approved Izervay™ (avacincaptad pegol intravitreal solution) for...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news